Suraksha Diagnostic Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Suraksha Diagnostic Ltd. on BSE

Load latest

Suraksha Diagnostic Ltd.

07 Apr 2025

304.70

-0.60%

Company Update

Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Intimation regarding update on acquisition under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Suraksha Diagnostic Ltd.

28 Mar 2025, 04:29PM

304.70

-0.60%

Company Update

Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you of the schedule of the Analysts/ Institutional Investors/ Organisation meeting to be held on Thursday 03 April 2025.

pdf

Suraksha Diagnostic Ltd.

27 Mar 2025

304.70

-0.60%

Company Update

Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Information about acquisition

pdf

Suraksha Diagnostic Ltd.

27 Mar 2025

304.70

-0.60%

Corp. Note

Suraksha Diagnostic Ltd - 544293 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with the applicable SEBI circulars, we wish to inform you that on the recommendation of the Audit Committee in its meeting held earlier today, the Board of Directors of the Company at its meeting held today, i.e. 27 March 2025 has inter-alia, considered and approved a proposal to make a strategic investment of an amount not exceeding ? 5.19 crore in Fetomat Wellness Private Limited ('Fetomat'), in cash, in one or more tranches.

pdf

Suraksha Diagnostic Ltd.

24 Mar 2025

304.70

-0.60%

SAST

Suraksha Diagnostic Ltd - 544293 - Closure of Trading Window

BSE India

Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and in terms of the Company''s Code of Conduct for regulating, monitoring and reporting of trading by insiders, the trading window will remain closed for all the designated person and their immediate relative from Tuesday 01 April, 2025 till 48hours after the declaration of the audited financial results (both standalone & consolidated) of the Company for the quarter and year ended 31 March 2025.

pdf

Suraksha Diagnostic Ltd.

07 Mar 2025

304.70

-0.60%

Company Update

Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release in respect of appointment of Chief Financial Officer (CFO) of the Company

pdf

Suraksha Diagnostic Ltd.

17 Feb 2025

304.70

-0.60%

Company Update

Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

BSE India

In continuation of our letter dated 16 January 2025, we wish to inform you that Mr. Amit Saraf, Chief Financial Officer of the Company has resigned from the closure of business hours of 15 February 2025.

pdf